MAPT and Alzheimer disease: It was found that the mRNA levels of Zn2+ transporters, including LIV1, ZIP1, ZnT1, ZnT4, and ZnT6 were increased in the cortex of postmortem brain tissues from AD patients, increasing the likelihood of interactions between Zn2+ and Aβ or tau protein in the brains [24].